S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Cell Therapy Expert Dr. Amit Patel Joins Regen BioPharma Inc. Scientific Advisory Board|
|Regen BioPharma Scheduled to Make Presentation at American Society for Hematology's 56th Annual Meeting in San Francisco December 6th - 9th|
|Regen BioPharma's Chief Scientific Officer Examines Potential Role of Immunotherapeutic Treatment for Ebola in Conjunction With Other Current Therapies|
|Regen BioPharma Files Patent Application on New Therapy That Uses the "Innate" Immune System to Kill Cancer|
|Regen BioPharma Completes Preclinical Experiments for dCellVax Breast Cancer Immune Therapy|
|Regen BioPharma Submits Experimental Protocol to FDA for HemaXellerate Aplastic Anemia Trial|
|Regen BioPharma Inc. Files IND Application With FDA for dCellVax Breast Cancer Immune Therapy|
|FDA Issues IND Number for Regen BioPharma's dCellVax Therapeutic Application, a Proposed Treatment for Breast Cancer|
|Regen BioPharma Acquires University of Toronto Cancer Stem Cell Intellectual Property|
Click above to view more mutual fund data and stats for bmsn - Bio-Matrix Scientific Group Inc.